Cormedi Marina Candido Visontai, Katayama Maria Lucia Hirata, Guindalini Rodrigo Santa Cruz, Faraj Sheila Friedrich, Folgueira Maria Aparecida Azevedo Koike
Departamento de Radiologia e Oncologia, Instituto do Cancer do Estado de Sao Paulo (ICESP), Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Departamento de Patologia, Instituto do Câncer do Estado de Sao Paulo (ICESP), Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Clinics (Sao Paulo). 2018 Sep 21;73(suppl 1):e651s. doi: 10.6061/clinics/2018/e651s.
Survival data for young adults (YA) with gastric cancer is conflicting and scarce in Brazil. The aim of this study was to compare the clinicopathological factors and survival rates of younger and older patients with gastric cancer.
Hospital registries for 294 gastric cancer patients from a reference cancer hospital in São Paulo, Brazil, were consulted for the retrieval of clinicopathological information and follow-up time. Patients were placed into the following groups: YA (≤40 years; N=71), older adult (OA: 41 to 65 years; N=129) and elderly (E: ≥66 years; N=94). Differences were assessed through Pearson's χ2 test, Kaplan-Meier analysis, Log rank test and Cox regression.
More YA were diagnosed with advanced disease (clinical stage III/IV: 86.7% YA, 69.9% OA, and 67% E); however, fewer E patients underwent surgery (64.3% YA, 72.7% OA, and 52.4% E). The median overall survival among all patients was 16 months, and the overall survival rate was not significantly different among the age groups (p=0.129). There were no significant differences in the disease-free survival rate. Metastatic disease at diagnosis (HR=4.84; p<0.01) was associated with an increased hazard of death for YA.
Overall survival was similar among age groups. Metastatic disease at diagnosis was the only factor associated with a poorer prognosis in YA. These results suggest that younger patients deserve special attention regarding the detection of early stage disease.
在巴西,青年胃癌患者的生存数据存在矛盾且较为匮乏。本研究旨在比较青年和老年胃癌患者的临床病理因素及生存率。
查阅巴西圣保罗一家癌症参考医院294例胃癌患者的医院登记资料,以获取临床病理信息和随访时间。患者被分为以下几组:青年组(≤40岁;n = 71)、成年组(OA:41至65岁;n = 129)和老年组(E:≥66岁;n = 94)。通过Pearson卡方检验、Kaplan-Meier分析、对数秩检验和Cox回归评估差异。
更多青年患者被诊断为晚期疾病(临床III/IV期:青年组86.7%,成年组69.9%,老年组67%);然而,接受手术的老年患者较少(青年组64.3%,成年组72.7%,老年组52.4%)。所有患者的中位总生存期为16个月,各年龄组的总生存率无显著差异(p = 0.129)。无病生存率无显著差异。诊断时出现转移性疾病(HR = 4.84;p < 0.01)与青年患者死亡风险增加相关。
各年龄组的总生存期相似。诊断时出现转移性疾病是青年患者预后较差的唯一相关因素。这些结果表明,在早期疾病检测方面,年轻患者值得特别关注。